Navigation Links
Gold nanoparticles give an edge in recycling CO2
Date:10/24/2013

PROVIDENCE, R.I. [Brown University] By tuning gold nanoparticles to just the right size, researchers from Brown University have developed a catalyst that selectively converts carbon dioxide (CO2) to carbon monoxide (CO), an active carbon molecule that can be used to make alternative fuels and commodity chemicals.

"Our study shows potential of carefully designed gold nanoparticles to recycle CO2 into useful forms of carbon," said Shouheng Sun, professor of chemistry and one of the study's senior authors. "The work we've done here is preliminary, but we think there's great potential for this technology to be scaled up for commercial applications."

The findings are published in the Journal of the American Chemical Society.

The idea of recycling CO2 a greenhouse gas the planet current has in excess is enticing, but there are obstacles. CO2 is an extremely stable molecule that must be reduced to an active form like CO to make it useful. CO is used to make synthetic natural gas, methanol, and other alternative fuels.

Converting CO2 to CO isn't easy. Prior research has shown that catalysts made of gold foil are active for this conversion, but they don't do the job efficiently. The gold tends to react both with the CO2 and with the water in which the CO2 is dissolved, creating hydrogen byproduct rather than the desired CO.

The Brown experimental group, led by Sun and Wenlei Zhu, a graduate student in Sun's group, wanted to see if shrinking the gold down to nanoparticles might make it more selective for CO2. They found that the nanoparticles were indeed more selective, but that the exact size of those particles was important. Eight nanometer particles had the best selectivity, achieving a 90-percent rate of conversion from CO2 to CO. Other sizes the team tested four, six, and 10 nanometers didn't perform nearly a
'/>"/>

Contact: Kevin Stacey
kevin_stacey@brown.edu
401-863-3766
Brown University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Stealth nanoparticles lower drug-resistant tumors defenses
2. Researchers figure out why gold nanoparticles can penetrate cell walls
3. Nanoparticles, pH phoresis could improve cancer drug delivery
4. MU researchers develop radioactive nanoparticles that target cancer cells
5. Trackable drug-filled nanoparticles -- a potential weapon against cancer
6. X-rays reveal uptake of nanoparticles by soya bean crops
7. Achilles heel: Popular drug-carrying nanoparticles get trapped in bloodstream
8. Nanoparticles reach new peaks
9. Study reports iron oxide nanoparticles effective for labeling human endothelial cells
10. Synthetic and biological nanoparticles combined to produce new metamaterials
11. UC Davis researchers develop new drug delivery system for bladder cancer using nanoparticles
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gold nanoparticles give an edge in recycling CO2
(Date:10/29/2014)... number of chemicals from household and industrial products are ... bodies. But for most of them, scientists have yet ... taken the first step toward doing that by estimating ... new method is published in the ACS journal ... and colleagues note that the risks to human health ...
(Date:10/29/2014)... in German . ... and Peter Schlögelhofer at the Max F. Perutz Laboratories ... University of Vienna dived into the process of meiosis ... display an inversion of the standard meiotic phases. The ... Nature Communications . , Meiosis is the two-step ...
(Date:10/29/2014)... all organisms in the living world compete with ... strongly in how much they invest into their ... eager to get access to high-quality resources, while ... use of the lower-quality resources that are left ... in animal and human societies seems to fluctuate ...
Breaking Biology News(10 mins):Meiotic cell division 'the other way round' 2Evolution of competitiveness 2Evolution of competitiveness 3
... used in California,s Central Valley, one of the world,s ... frog species miles from farmland. Writing in Environmental ... Pacific Tree Fogs in remote mountain areas, including national ... pesticides by the elements. California,s Central Valley is ...
... 25, 2013 The following statement is being issued by Robbins Geller ... Pacific Biosciences Securities Litigation SUPERIOR COURT OF THE ... IN RE PACIFIC BIOSCIENCES OF CALIFORNIA ... CIV509210 SUMMARY NOTICE OF PROPOSED SETTLEMENT OF CLASS ACTION Hon. Marie ...
... researchers have developed a computer-aided method that uses ... rapid advances toward personalized health care, disease management ... V. Chawla and his doctoral student, Darcy A. ... Recommendation Engine (CARE) for personalized disease risk predictions ...
Cached Biology News:Pesticides contaminate frogs from Californian National Parks 2Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 2Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 3Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 4Notre Dame researchers develop system that uses a big data approach to personalized healthcare 2
(Date:10/30/2014)...  Regado Biosciences, Inc. (Nasdaq: RGDO ), ... and live audio webcast on Thursday, November 6, 2014, ... 2014 financial results. Interested participants and investors ... for domestic callers or (412) 902-4276 for international callers. ... investor relations section of the Regado website at ...
(Date:10/27/2014)... 27, 2014 The new research ... (High & Medium), Sub-type (Primary & Secondary), and ... & Transportation & Power Generation) - Trends and ... market with analysis and forecasting of the market ... Tables with 52 Figures spread through 146 Pages ...
(Date:10/27/2014)... 2014 The “Molecular Diagnostic Market ... Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, ... - Global Forecast to 2018” provides a detailed ... current market trends, and strategies impacting the global ... forecasts of the revenue and share analysis. , ...
(Date:10/27/2014)... Mass. , Oct. 27, 2014 ... "Company"), a worldwide leader in the development and ... the life sciences research market, today announced that ... presented a novel, accurate, highly reproducible, and robust ... – routine high-throughput protein analysis on small needle ...
Breaking Biology Technology:Regado Biosciences to Provide Third Quarter 2014 Financial Results 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 2Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 3Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 4Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 5Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 2Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 3Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 4Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 5
... EXTON, Pa., June 2, 2011 Morphotek®, Inc., a ... commenced a multi-center, phase II study of MORAb-004 for ... MORAb-004, a potentially first-in-class monoclonal antibody that specifically binds ... therapy comparing its safety and therapeutic activity at two ...
... a medical explanation for why exercise is good for the ... that started in Dr. Ian Phillips, lab at Keck Graduate ... 29 that keeps hearts healthy even under intense exercise. ... of why exercise is good for you," said Phillips, KGI,s ...
... (NASDAQ: SQNM ), a life sciences company ... its subsidiary Sequenom Center for Molecular Medicine® (Sequenom CMM) ... Valley Bank’s San Diego-based team. Sequenom will use proceeds ... of new products and other near term growth initiatives. ...
Cached Biology Technology:Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 3Scientists Discover Gene Regulator That Helps Hearts Through Exercise 2Sequenom Enters Into New $30.0 Million Credit Facility 2Sequenom Enters Into New $30.0 Million Credit Facility 3Sequenom Enters Into New $30.0 Million Credit Facility 4
This antibody detects an ~25 kDa band, corresponding to the expected molecular mass of Rab3A, on immunoblots. The antibody specificity is confirmed in peptide inhibition immunoblotting studies....
... reactive against the complex IV assembly factor SURF1. ... cultured cells. SURF1 is an important assembly factor ... participate in the folding of subunit II and ... SURF1, particularly ones that result in an absence ...
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
Biology Products: